Clinical Trials · NCT06842186
A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
- Phase
- Phase 1/Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Wave Life Sciences USA, Inc.
- Enrollment
- 400
- Start date
- Jan 2025
- Locations
- 7 sites, 4 countries
- Primary endpoint
- The proportion of participants with treatment emergent adverse events